LEADER 00813nam0-22002771i-450- 001 990005987310403321 005 19980601 035 $a000598731 035 $aFED01000598731 035 $a(Aleph)000598731FED01 035 $a000598731 100 $a19980601d1912----km-y0itay50------ba 105 $a--------00-yy 200 1 $aDei diritti reali immobiliari quali beni capaci d'ipoteca$fCarmelo Floreno. 210 $aCatania$cN. Giannotta$d1912 676 $a346.043 700 1$aFloreno,$bCarmelo$0227752 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990005987310403321 952 $aVIII E 109$b2732$fFGBC 952 $aDONO SCUTO VIII 9$b29024*$fFGBC 959 $aFGBC 996 $aDei diritti reali immobiliari quali beni capaci d'ipoteca$9583734 997 $aUNINA DB $aGIU01 LEADER 01884nas 2200601-a 450 001 996198605803316 005 20230227213019.0 011 $a1937-3392 035 $a(OCoLC)156908615 035 $a(CKB)1000000000323524 035 $a(CONSER)--2007213659 035 $a(MiFhGG)2EQD 035 $a(MiAaPQ)40313 035 $a(EXLCZ)991000000000323524 100 $a20070723a20089999 s-- a 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aTissue engineering$hPart C$iMethods 210 $aNew Rochelle, NY $cMary Ann Liebert, Inc 300 $aRefereed/Peer-reviewed 311 $a1937-3384 531 $aTISSUE ENGINEERING 531 $aTISSUE ENG PART C METHODS 531 $aTISSUE ENGINEERING, PART C 531 $aTISSUE ENG. PART C 531 $aTISSUE ENGINEERING - PART C 531 $aTISSUE ENGINEERING PART C 606 $aTissue engineering$vPeriodicals 606 $aBiomedical materials$vPeriodicals 606 $aBiomedical engineering$vPeriodicals 606 $aTissue Engineering$xmethods 606 $aGuided Tissue Regeneration 606 $aBiomedical engineering$2fast$3(OCoLC)fst00832568 606 $aBiomedical materials$2fast$3(OCoLC)fst00832586 606 $aTissue engineering$2fast$3(OCoLC)fst01151484 608 $aPeriodical 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 615 0$aTissue engineering 615 0$aBiomedical materials 615 0$aBiomedical engineering 615 12$aTissue Engineering$xmethods 615 22$aGuided Tissue Regeneration 615 7$aBiomedical engineering. 615 7$aBiomedical materials. 615 7$aTissue engineering. 906 $aJOURNAL 912 $a996198605803316 996 $aTissue engineering$9787312 997 $aUNISA